LABORATORIO FARMAC.ERFO (RK7) — Tangible Net Worth Ratio
LABORATORIO FARMAC.ERFO (RK7) has a Tangible Net Worth Ratio of 54.4% as of June 2024. This metric is calculated by deducting intangible assets (€3.44 Million) from net assets (€7.54 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See RK7 net asset value for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
LABORATORIO FARMAC.ERFO Tangible Net Worth Ratio (2021–2023)
This chart shows how LABORATORIO FARMAC.ERFO's Tangible Net Worth Ratio has changed across 2 annual periods from 2021 to 2023. As of June 2024, the ratio stands at 54.4%, reflecting net assets of €7.54 Million with intangible assets of €3.44 Million EUR. Also explore RK7 net assets growth trend to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for LABORATORIO FARMAC.ERFO (2021–2023)
The table below presents the year-by-year Tangible Net Worth Ratio for LABORATORIO FARMAC.ERFO from 2021 to 2023, covering 2 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see LABORATORIO FARMAC.ERFO market cap and net worth.
| Year | Tangible NW Ratio | Net Assets (EUR) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2023 | 54.7% | €7.88 Million | €3.57 Million | €10.15 Million | ▲ +4.8 pp |
| 2021 | 49.9% | €4.73 Million | €2.37 Million | €6.93 Million | — |